UPDATE 1-Merck KGaA, GSK suffer lung cancer drug setback
(Adds details on drug, GSK)By Ludwig BurgerFRANKFURT, Jan 20 (Reuters) - Merck KGaA's drug development programme has suffered a setback with the most important clinical trial of its cancer drug hopeful bintrafusp alfa stopped because the treatment...
Read more